Martek Announces Addition to Its Board of Directors

COLUMBIA, Md., May. 16 /PRNewswire/ --

COLUMBIA, Md., May 16 /PRNewswire-FirstCall/ -- Martek Biosciences today announced the election of Michael G. Devine to its board of directors and audit committee.

Mr. Devine retired from public accounting in 2003 after a successful 24-year career primarily spent as a partner with Arthur Andersen LLP and later with Deloitte & Touche LLP. During his years at Arthur Andersen, Mr. Devine served in many technical leadership capacities including being a member of the firm's worldwide technology industries technical consultation group and being the southeastern United States technical coordinator for the software industry. After his retirement from public accounting, Mr. Devine served from 2004 to 2007 as the chief financial officer of Secure Software, Inc., a software developer.

Mr. Devine holds a master of business administration degree from Penn State University and a bachelor of arts degree from Rider College.

"We are pleased that Mike Devine has accepted a position on Martek's Board," said Robert J. Flanagan, Martek's chairman of the board. "Mike's experience and expertise will make him a great asset to the board and the audit committee."

Martek Biosciences Corporation is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The company produces life'sDHA(TM), a sustainable and vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, beverages, infant formula, and supplements. The company also produces life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, from a sustainable, vegetarian source, for use in infant formula. For more information on Martek Biosciences Corporation, visit http://www.martek.com.

CONTACT Cassie France-Kelly Public Relations (443) 542-2116 cfrancekelly@martek.com Kyle Stults Investor Relations (410) 740-0081 investors@martek.com